Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions

Wednesdavy July 1io

- - - - - - - -- j, - IF -

Poster Groupings
Track A Pathogenesis
Immunology
Venue Palacio 4, level 8
Track B Antiretroviral Therapies
Other HIV Therapies
Hepatitis Virus
Vaccines
Immune Interventions
Venue Palacio 4, level 7
Track C Descriptive Epidemiology/Surveillance
Markers, Cofactors, Therapies and Outcomes
Venue Palacio 4, level 6
Track D Behavioral and Social Interventions for Primary
Prevention of HIV
Interventions Linking HIV Prevention with Other
Prevention and Care Programs
Venue Palacio 4, level 5
Track E Civil Society, Non-Governmental and CommunityBased Organizations
Sexuality
Sex Work
Unspecified
Venue Palacio 4, level 4
Track F HIV/AIDS Prevention
Venue Palacio 4, level 3
Track G Interactions Between Other Policy Areas
and HIV/AIDS
Actors' Roles and Responsibilities
Unspecified
Venue Palacio 4, level 2
WePeA5713 Relationship between Tonsillar Tissue Viral
Burden (TTVL) and Plasma Viral Load (PVL),
peripheral blood T lymphocyte subsets and
Lymphoproliferative Responses (LPR)
F Garcia, M Arnedo, M Plana, C Gil, M Caballero,
L Alos, E Martinez, J M Miro, J L Blanch, A Cruceta,
G Mestre, T Pumarola, T Gallart, J M Gatell (Spain)
WePeA5714 Cell-derived membrane protein profile and
quasispecies evolution in H IV from plasma and
spinal fluid of AIDS patients
/ Abbate, G Cappiello, R Longo, A Ursitti,
S Calcaterra, A Spano, M R Capobianchi (Italy)
WePeA5715 Shedding of human herpesvirus-8 in oral and
genital secretions from HIV-1 positive and HIV-1
negative women
M M Taylor', B Chohan', L Lavreys', M L Huang',
L Corey', B Richardson', R Ashley, K Mandaliya2
I Bwayo2, I Kreiss' ('United States; 2Kenya)
WePeA5716 HIV-i in genital tract and plasma of women:
compartmentalization of both viral sequences
and coreceptor usage
K Sherefa-Kemal B Foley, H Burger, K Anastos,
H Minkoff, C Ramirez Kitchen, W Gao, E Robison,
S Holman, C Dehner, WA Meyer I/I, A Landay,
A Kovacs, I Bremer, K Davenny, B Weiser
(United States)
WePeA5717 Characterisation of epithelial cells from human
milk and their sensitivity to HIV strains
M Ziccheddu, C Serra, A Biolchini, G Arru, A Dolei

(Italy)

WePeA5718 Evaluation of a method to quantify HIV-1 nucleic
acids in female genital tract
A Gimeno I Portilla, J Plazas, I Sdnchez-Payd,
M Ochando, E Merino, V Boix, C Llopis, J Polache,
MA Pardo, R Sdnchez, / Gascdn (Spain)
WePeA5719 HIV-1 provirus in the peripheral CD4+ T
lymphocytes from the HIV-1 infected patients
under highly active antiretroviral therapy
T Kaneda, T Hagiwara, J Hattori, M Utsumi (Japan)
WePeA572o Detection and quantification of HIV-1 provirus by
real-time PCR and PNA-ISH
K Wada, H Nagai, T Hagiwara, N Hotta, M Utsumi,
T Kaneda (Japan)
WePeA5721 Response of HIV RNA carrying CD4+ and CD8+ T
lymphocytes in HIV infected patients during
HAART using ultrasensitive fluorescence in situ
hybridisation (UFISH)
A Rubbert A Woehrmann, D Passon, A Juette,
B Salzberger, G Faetkenheuer (Germany)
WePeA5722 Evaluation of Persistence and Residual
Replication of HIV-1 in patients on HAART with
suppressed plasma viremia by analysis of
proviral HIV-1 DNA, HIV-1 DNA preintegration
circles and immune activation in the peripheral
blood of patients on HAART with suppressed
plasma viremia
T Harrer J Hauber, P Law, M Schmitt,
E Schwingel, J R Kalden, I Hauber (Germany)
WePeA5723 Protease diversity changes in HIV-i infected
individuals receiving highly active antiretroviral
therapy
MA Martinez, M Parera, B Clotet (Spain)
WePeA5724 Detecting the residual replication level to
potentiate HAART regimen for a salvage therapy
K Yoshimura T Kimura, F Wang, J Kim, A Koito,
S Matsushita (apan)
WePeA5725 Towards therapy for the reservoir of human
immunodeficiency virus type 1 in resting T cells
D M M Marqolis, H] JJohnson, L L Y Yisastigui
(United States)
WePeA5726 Establishment of quantitative assay for cellular
HIV-i mRNA by real-time PCR
H Nagai, K Wada, Y Tawada, T Morishita,
M Utsumi, Y Nishiyama, T Kaneda (Japan)
WePeA5727 Evolution of CD4 and CKR usage by SIV during in
vitro xenoinfection
S fyengarI G Finny, H Zhang, C Chancey,
D H Schwartz (United States)
WePeA5728 Reduced fitness of HIV-1 resistant to CXCR4
antagonists
M Armand-Ugon', M Quinones-Mateu2,
A Gutierrez', J Barretina', J Blanco', D Schols3,
E De Clercq3, B Clotet', JA Este'
('Spain; 2United States; 3Belgium)
WePeA573o HIV-i protease mutations as potential cause for
reduced viral fitness in therapy-naive individuals
Y Maerki, G R Kaufmann, T Klimkait, M Battegay
(Switzerland)
WePeA5731 Longitudinal study of viral load in purified cell
subsets from patients with Primary H IV Infection
(PHI)
P Biswas M Malnati, A Galli, B Capiluppi,
S Piergiovanni, G Scarlatti, A Lazzarin, P Lusso,
G Tambussi (Italy)
WePeA5732 Unintegrated 2LTR circular DNA is a possible
marker of HIV-i cryptic replication
0 E Varnier I L McDermott, F Bertolotti, I Martini,

/ Levreri, G Murdaca, A Campelli, F Puppo (Italy)

Wednesday

154 Final Program